Goodwill and Intangible Assets (Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Aug. 22, 2022	Feb. 17, 2022	Dec. 31, 2021
Goodwill [Line Items]
Goodwill	$ 15,995		$ 15,995				$ 0
Amortization expense	1,511	$ 0	1,511	$ 0
In-process research and development | Collaboration agreement
Goodwill [Line Items]
Amortization expense			0
La Jolla Pharmaceutical Company
Goodwill [Line Items]
Goodwill					$ 12,711
Future amortization expense, remainder of 2022	3,500		3,500
Future amortization expense, 2023	13,800		13,800
Future amortization expense, 2024	13,800		13,800
Future amortization expense, 2025	13,800		13,800
Future amortization expense, 2026	13,800		13,800
Future amortization expense, thereafter	78,000		78,000
Intangible assets pertain to product rights and developed technologies	152,500		152,500		$ 152,500
Entasis Therapeutics Holdings Inc
Goodwill [Line Items]
Goodwill						$ 3,284
Intangible assets pertain to product rights and developed technologies	107,500		107,500			$ 107,500
Entasis Therapeutics Holdings Inc | Collaboration agreement
Goodwill [Line Items]
Intangible assets pertain to product rights and developed technologies	35,400		35,400
Entasis Therapeutics Holdings Inc | In-process research and development
Goodwill [Line Items]
Intangible assets pertain to product rights and developed technologies	$ 72,100		$ 72,100